GlassScriptPhysician profile
Michael Muscatella
NPI 1578667515
$1,732.83
in general payments reported to CMS, 2019-2025
13 companies · $385 in 2025
The $385 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $504 · 2020: $35.55 · 2022: $104 · 2023: $581 · 2024: $123 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $642 · Travel and Lodging: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $641.93 |
| Travel and Lodging | $447.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $590.28 | 2019-2023 | |
| Treace Medical Concepts, INC. | $375.98 | 2022-2025 | |
| Depuy Synthes Sales INC. | $344.05 | 2019-2024 | N/A, Hammerlock |
| Smith+Nephew, INC. | $115.81 | 2023-2025 | Grafix Pl, Grafix Xc, Grafix |
| Orthofix Medical, INC. | $52.74 | 2022-2023 | Physio-Stim |
| Wright Medical Technology, INC. | $47.91 | 2019 | |
| Paratek Pharmaceuticals, INC. | $45.83 | 2024-2025 | Nuzyra |
| Organogenesis INC. | $43.11 | 2022-2023 | Puraply |
| Tactile Systems Technology INC | $35.55 | 2020 | |
| Kerecis Limited | $25.23 | 2022 | |
| Merck Sharp & Dohme LLC | $24.85 | 2019 | |
| International Life Sciences | $19.10 | 2024 | Flexband |
| Pfizer INC. | $12.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Muscatella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.